Medication to stop drinking alcohol
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Medications to Stop Drinking Alcohol: An Overview
Introduction to Alcohol Use Disorders (AUDs)
Alcohol use disorders (AUDs) are complex conditions characterized by an inability to control alcohol consumption despite adverse consequences. Chronic alcohol intake can lead to significant health issues, including brain and liver damage, and even death. Effective treatment often requires a combination of behavioral therapy and pharmacotherapy to manage withdrawal symptoms and reduce cravings.
FDA-Approved Medications for AUDs
Naltrexone
Naltrexone is an FDA-approved medication that helps reduce cravings and relapse rates in individuals with AUDs . It works by blocking the euphoric effects of alcohol, thereby reducing the desire to drink. Clinical trials have shown that naltrexone can be effective in extending the time to relapse and reducing the number of heavy drinking days .
Acamprosate
Acamprosate is another FDA-approved medication that helps maintain abstinence by stabilizing chemical imbalances in the brain caused by chronic alcohol consumption . It has been shown to increase abstinence rates, although its effects are considered modest.
Disulfiram
Disulfiram, also known as Antabuse, has been used for decades to treat AUDs. It works by causing unpleasant reactions when alcohol is consumed, thereby deterring drinking. However, its effectiveness is inconsistent, and it is often associated with compliance issues and significant adverse effects .
Emerging Pharmacotherapies
Gabapentin
Gabapentin, an anticonvulsant, has shown promise in reducing alcohol cravings and improving sleep during the early stages of abstinence. When combined with naltrexone, it has been found to be more effective than naltrexone alone in reducing heavy drinking days and the number of drinks per drinking day. However, its long-term efficacy remains to be fully established.
Topiramate
Topiramate, another anticonvulsant, has been investigated for its potential to reduce alcohol consumption. Preliminary studies suggest that it may help decrease heavy drinking and increase abstinence rates, although more research is needed to confirm these findings .
Baclofen
Baclofen, a GABA(B) agonist, has shown mixed results in clinical trials. While some studies have reported reductions in drinking and cravings, others have found no significant difference compared to placebo. Further research is required to determine its efficacy and safety in treating AUDs.
Other Medications Under Investigation
Nalmefene
Nalmefene is being explored for its potential to reduce alcohol consumption rather than promote complete abstinence. It has shown promise in clinical trials, but its development status remains unclear.
Antidepressants and Antipsychotics
Certain antidepressants like sertraline and fluoxetine may help reduce alcohol consumption in patients with co-occurring mood disorders. Antipsychotics such as aripiprazole and flupenthixol are also being investigated for their potential benefits in treating AUDs .
Conclusion
While several medications are available to help manage AUDs, no single drug is universally effective. Naltrexone, acamprosate, and disulfiram are the primary FDA-approved options, each with its own set of benefits and limitations. Emerging therapies like gabapentin, topiramate, and baclofen offer additional hope but require further validation. Comprehensive treatment often involves a combination of pharmacotherapy and behavioral interventions to achieve the best outcomes.
Sources and full results
Most relevant research papers on this topic